Abstract
Objective: To investigate whether transdermal low dose estradiol treatment induces changes in mammographic density or heterogeneity compared to raloxifene. Secondarily, if these changes relate to changes in bone formation/resorption markers, and if these findings indicate elevation of breast cancer risk by treatment.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Menopause |
Vol/bind | 16 |
Udgave nummer | 4 |
Sider (fra-til) | 785-791 |
Antal sider | 7 |
ISSN | 1072-3714 |
DOI | |
Status | Udgivet - 2009 |